Cargando…
Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia
OBJECTIVES: To investigate whether cerebrospinal fluid levels of neuron-specific enolase (CSF-NSE) during the first 72 hours correlate with other tools used to assess ongoing brain damage, including clinical grading of hypoxic-ischemic encephalopathy (HIE), abnormal patterns in amplitude integrated...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263594/ https://www.ncbi.nlm.nih.gov/pubmed/32479533 http://dx.doi.org/10.1371/journal.pone.0234082 |
_version_ | 1783540817257824256 |
---|---|
author | León-Lozano, Marisol-Zulema Arnaez, Juan Valls, Ana Arca, Gemma Agut, Thais Alarcón, Ana Garcia-Alix, Alfredo |
author_facet | León-Lozano, Marisol-Zulema Arnaez, Juan Valls, Ana Arca, Gemma Agut, Thais Alarcón, Ana Garcia-Alix, Alfredo |
author_sort | León-Lozano, Marisol-Zulema |
collection | PubMed |
description | OBJECTIVES: To investigate whether cerebrospinal fluid levels of neuron-specific enolase (CSF-NSE) during the first 72 hours correlate with other tools used to assess ongoing brain damage, including clinical grading of hypoxic-ischemic encephalopathy (HIE), abnormal patterns in amplitude integrated electroencephalography (aEEG), and magnetic resonance imaging (MRI), as well as with the neurodevelopmental outcomes at two years of age. MATERIAL AND METHODS: Prospective observational study performed in two hospitals between 2009 and 2011. Forty-three infants diagnosed with HIE within 6 hours of life were included. HIE was severe in 20 infants, moderate in 12, and mild in 11. Infants with moderate-to-severe HIE received whole-body cooling. Both the HIE cohort and a control group of 59 infants with suspected infection underwent measurement of CSF-NSE concentrations at between 12 and 72 hours after birth. aEEG monitoring was started at admission and brain MRI was performed within the first 2 weeks. Neurodevelopment was assessed at 24 months. RESULTS: The HIE group showed higher levels of CSF-NSE than the control group: median 70 ng/ml (29; 205) vs 10.6 ng/ml (7.7; 12.9); p <0.001. Median levels of CSF-NSE in infants with severe, moderate, and mild HIE were 220.5 ng/ml (120.5; 368.8), 45.5 ng/ml (26, 75.3), and 26 ng/ml (18, 33), respectively. CSF-NSE levels correlated were significantly higher in infants with seizures, abnormal aEEG, or abnormal MRI, compared to those without abnormalities. Infants with an adverse outcome showed higher CSF-NSE levels than those with normal findings (p<0.001), and the most accurate CSF-NSE cutoff level for predicting adverse outcome in the whole cohort was 108 ng/ml and 50ng/ml in surviving infants. CONCLUSIONS: In the era of hypothermia, CSF-NSE concentrations provides valuable information as a clinical surrogate of the severity of hypoxic-ischemic brain damage, and this information may be predictive of abnormal outcome at two years of age. |
format | Online Article Text |
id | pubmed-7263594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-72635942020-06-10 Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia León-Lozano, Marisol-Zulema Arnaez, Juan Valls, Ana Arca, Gemma Agut, Thais Alarcón, Ana Garcia-Alix, Alfredo PLoS One Research Article OBJECTIVES: To investigate whether cerebrospinal fluid levels of neuron-specific enolase (CSF-NSE) during the first 72 hours correlate with other tools used to assess ongoing brain damage, including clinical grading of hypoxic-ischemic encephalopathy (HIE), abnormal patterns in amplitude integrated electroencephalography (aEEG), and magnetic resonance imaging (MRI), as well as with the neurodevelopmental outcomes at two years of age. MATERIAL AND METHODS: Prospective observational study performed in two hospitals between 2009 and 2011. Forty-three infants diagnosed with HIE within 6 hours of life were included. HIE was severe in 20 infants, moderate in 12, and mild in 11. Infants with moderate-to-severe HIE received whole-body cooling. Both the HIE cohort and a control group of 59 infants with suspected infection underwent measurement of CSF-NSE concentrations at between 12 and 72 hours after birth. aEEG monitoring was started at admission and brain MRI was performed within the first 2 weeks. Neurodevelopment was assessed at 24 months. RESULTS: The HIE group showed higher levels of CSF-NSE than the control group: median 70 ng/ml (29; 205) vs 10.6 ng/ml (7.7; 12.9); p <0.001. Median levels of CSF-NSE in infants with severe, moderate, and mild HIE were 220.5 ng/ml (120.5; 368.8), 45.5 ng/ml (26, 75.3), and 26 ng/ml (18, 33), respectively. CSF-NSE levels correlated were significantly higher in infants with seizures, abnormal aEEG, or abnormal MRI, compared to those without abnormalities. Infants with an adverse outcome showed higher CSF-NSE levels than those with normal findings (p<0.001), and the most accurate CSF-NSE cutoff level for predicting adverse outcome in the whole cohort was 108 ng/ml and 50ng/ml in surviving infants. CONCLUSIONS: In the era of hypothermia, CSF-NSE concentrations provides valuable information as a clinical surrogate of the severity of hypoxic-ischemic brain damage, and this information may be predictive of abnormal outcome at two years of age. Public Library of Science 2020-06-01 /pmc/articles/PMC7263594/ /pubmed/32479533 http://dx.doi.org/10.1371/journal.pone.0234082 Text en © 2020 León-Lozano et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article León-Lozano, Marisol-Zulema Arnaez, Juan Valls, Ana Arca, Gemma Agut, Thais Alarcón, Ana Garcia-Alix, Alfredo Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia |
title | Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia |
title_full | Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia |
title_fullStr | Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia |
title_full_unstemmed | Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia |
title_short | Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia |
title_sort | cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263594/ https://www.ncbi.nlm.nih.gov/pubmed/32479533 http://dx.doi.org/10.1371/journal.pone.0234082 |
work_keys_str_mv | AT leonlozanomarisolzulema cerebrospinalfluidlevelsofneuronspecificenolasepredicttheseverityofbraindamageinnewbornswithneonatalhypoxicischemicencephalopathytreatedwithhypothermia AT arnaezjuan cerebrospinalfluidlevelsofneuronspecificenolasepredicttheseverityofbraindamageinnewbornswithneonatalhypoxicischemicencephalopathytreatedwithhypothermia AT vallsana cerebrospinalfluidlevelsofneuronspecificenolasepredicttheseverityofbraindamageinnewbornswithneonatalhypoxicischemicencephalopathytreatedwithhypothermia AT arcagemma cerebrospinalfluidlevelsofneuronspecificenolasepredicttheseverityofbraindamageinnewbornswithneonatalhypoxicischemicencephalopathytreatedwithhypothermia AT agutthais cerebrospinalfluidlevelsofneuronspecificenolasepredicttheseverityofbraindamageinnewbornswithneonatalhypoxicischemicencephalopathytreatedwithhypothermia AT alarconana cerebrospinalfluidlevelsofneuronspecificenolasepredicttheseverityofbraindamageinnewbornswithneonatalhypoxicischemicencephalopathytreatedwithhypothermia AT garciaalixalfredo cerebrospinalfluidlevelsofneuronspecificenolasepredicttheseverityofbraindamageinnewbornswithneonatalhypoxicischemicencephalopathytreatedwithhypothermia |